Intended for healthcare professionals

Letters Ranibizumab and bevacizumab

Prescribing bevacizumab off-label contravenes GMC advice

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7131 (Published 08 November 2011) Cite this as: BMJ 2011;343:d7131